Skip to content

Effect of using infrared vein finder on the success rate of venipuncture in obese diabetic patients

Effect of Near Infrared Vein Finder Technology on Successful rate of Cannulation in Obese Diabetic Patients

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20210705051797N1
Enrollment
66
Registered
2021-08-05
Start date
2021-08-23
Completion date
Unknown
Last updated
2021-08-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obese Diabetic Patients. Type 2 diabetes mellitus with other specified complication

Interventions

Intervention 1: In the intervention group, an infrared vein finder will be used to examine the patient's veins and catheter insertion. Intervention 2: In the control group, routine procedures are used

Sponsors

Mashhad University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Diagnose diabetes for at least two months Body mass index 30 and above Having patients' informed consent Age between 18-70 years No history of vein problems Not having vein problems such as phlebitis and extremities edema

Exclusion criteria

Exclusion criteria: Reluctance to continue participating in the study Exacerbation of the disease or occurrence of an unpleasant accident for the patient such as severe hemorrhage and hematoma Failing insertion of cannula at more than fourth attempt

Design outcomes

Primary

MeasureTime frame
The number of attempts of cannulation. Timepoint: during the study. Method of measurement: Counting the number of times that catheter is inserted into the patient's skin.;Duration of catheter insertion. Timepoint: duration of the study. Method of measurement: Measure the time required for catheter insertion using a watch.

Secondary

MeasureTime frame
No having. Timepoint: no having. Method of measurement: no having.

Countries

Iraq

Contacts

Public ContactProfessor; Hossein Karimi Moonaghi, PhD.

Mashhad University of Medical Sciences

karimih@mums.ac.ir+98 51 3859 1511

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026